Serum adiponectin concentrations have been shown to be inversely correlated with the severity of insulin resistance in patients with T2DM.[30] Consistent with the findings of previous studies,[18,31,32] the present study showed that a lower level of adiponectin was present in patients with newly diagnosed T2DM who were obese than in those who had normal BMI. Here, ADIPOQ is linked to Insulin resistance.